Print

Depomed, Inc. (DEPO) And Madaus Enter Into Agreement For ProQuin XR In Europe  
11/29/2005 10:51:42 AM

MENLO PARK, Calif. & PADOVA, Italy--(BUSINESS WIRE)--Nov. 29, 2005--Depomed, Inc. (Nasdaq: DEPO) and Madaus S.r.l. today announced that the companies have entered into a distribution and supply agreement for ProQuin(R) XR, Depomed's once-daily, extended release formulation of the antibiotic ciprofloxacin.
//-->